| Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain (NCT04156802) | Wake Forest University Health Sciences | 2020-06-15 |
| The Effect of Self-Forgiveness on Self-Stigma in Addiction. (NCT03971097) | University of Pittsburgh | 2019-08-01 |
| Impact of Lofexidine on Stress, Craving and Opioid Use (NCT03718065) | Medical University of South Carolina | 2019-06-26 |
| Remote Observed Dosing of Suboxone to Improve Clinical Practice (NCT03769025) | University of Pennsylvania | 2019-04-01 |
| Developing Brain Stimulation as a Treatment for Chronic Pain in Opiate Dependent (NCT03681769) | Medical University of South Carolina | 2019-02-22 |
| Imaging Synaptic Density in Cocaine and Opiate Addiction In Vivo Using 11UCB-J PET (NCT03527485) | Yale University | 2019-01-01 |
| Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder (NCT03538444) | Medical University of South Carolina | 2018-09-28 |
| Cognitive Function Before and After Opioid Reduction in Patients With Chronic Pain (NCT03036917) | Zealand University Hospital | 2018-01-01 |
| A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic (NCT03235154) | Community Research Initiative of New England | 2017-10-11 |
| Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting (NCT03662529) | Hunter Holmes Mcguire Veteran Affairs Medical Center | 2017-06-05 |
| Medicinal Dependence and Chronic Pain: Addictive Evaluation in CETD (NCT03635346) | University Hospital, Brest | 2016-06-03 |
| Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction (NCT02801357) | USWM, LLC (dba US WorldMeds) | 2016-06-01 |
| Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone (NCT02617628) | University of Pennsylvania | 2016-01-01 |
| Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence (NCT02602795) | Rhode Island Hospital | 2015-12-01 |
| Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers (NCT02477267) | INSYS Therapeutics Inc | 2015-06-01 |
| Substance Dependence Satisfaction With Care and Quality Of Life (NCT02894476) | Central Hospital, Nancy, France | 2014-04-01 |
| Clinical Efficacy and Serum Proteomic Profiling of Suan-Zao-Ren Tang for Sleep Disturbance During Methadone Maintenance (NCT01913418) | China Medical University, Taiwan | 2013-07-01 |
| Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone (NCT01882361) | University of Pennsylvania | 2013-06-01 |
| Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence (NCT01848054) | Orexo AB | 2013-06-01 |
| Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia (NCT01863251) | Yale University | 2013-05-01 |
| Naloxone Methadone Combination (NAMEKO) (NCT01160432) | Kuopio University Hospital | 2013-05-01 |
| Remote Observed Dosing to Increase Suboxone Compliance (NCT01779973) | University of Pennsylvania | 2013-02-01 |
| Oxytocin in Opiate Dependence: A Pilot Study of the Effects of Intranasal Oxytocin on Emotional Processes and Stress Responses in Patients With Opiate Dependence (NCT02052258) | MacDonald, Kai, M.D. | 2013-01-01 |
| Variation of COMT Val158Met Polymorphism Between COM-ON Patients and METHADOSE Patients (NCT01570699) | Assistance Publique - Hôpitaux de Paris | 2012-12-01 |
| A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment (NCT01802515) | Yale University | 2012-12-01 |
| Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence (NCT01690546) | Paolo Mannelli | 2012-09-01 |
| Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment (NCT01376570) | Albert Einstein College of Medicine | 2012-06-01 |
| Developing a Smoking Cessation Intervention for Methadone Maintained Smokers (NCT01393392) | Rutgers, The State University of New Jersey | 2011-10-01 |
| Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia (NCT01389167) | Yale University | 2011-09-01 |
| Reengineering Methadone Treatment Study of Patient-centered Methadone Treatment (NCT01442493) | Friends Research Institute, Inc. | 2011-09-01 |
| The Clinical Efficacy of Acupuncture as an Adjunct to Methadone Treatment Services for Heroin Addicts (NCT01512433) | China Medical University, Taiwan | 2011-08-01 |
| Compliance Monitoring in Real Time During Opioid Substitution Treatment (NCT01183130) | Kuopio University Hospital | 2011-08-01 |
| Cognitive-Behavioral Therapy for Pain and Opioid Dependence in Methadone Maintenance Treatment (NCT01334580) | Yale University | 2011-04-01 |
| Behavioral Drug and HIV Risk Reduction Counseling With MMT in China (NCT01389180) | Yale University | 2010-12-01 |
| Electronic Compliance Monitoring in Opioid Substitution Treatment (NCT01182402) | Kuopio University Hospital | 2010-09-01 |
| Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail (NCT01180647) | NYU Langone Health | 2010-05-01 |
| Clinical Trial of Integrated Treatment for Pain and Opioid Dependence (NCT00634803) | Yale University | 2009-09-01 |
| Linking Hospitalized Injection Drug Users to Buprenorphine (NCT00987961) | Butler Hospital | 2009-09-01 |
| Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan (NCT00901875) | Indivior Inc. | 2009-03-01 |
| ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals (NCT00834080) | Alkermes, Inc. | 2009-03-01 |
| Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence (NCT00555425) | Yale University | 2008-07-01 |
| ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence (NCT00678418) | Alkermes, Inc. | 2008-06-01 |
| Entry Into Comprehensive Methadone Treatment Via Interim Maintenance (NCT00712036) | Friends Research Institute, Inc. | 2008-06-01 |
| Employment-Based Depot Naltrexone Clinical Trial II (NCT00684775) | Johns Hopkins University | 2008-05-01 |
| Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444) (NCT00725608) | Indivior Inc. | 2008-05-01 |
| Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603) (NCT00723749) | Indivior Inc. | 2008-03-01 |
| A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED) (NCT00605033) | Indivior Inc. | 2008-03-01 |
| Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction (NCT00609089) | University of Cincinnati | 2008-03-01 |
| A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED) (NCT00604188) | Merck Sharp & Dohme LLC | 2008-02-22 |
| Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China (NCT00757744) | Yale University | 2007-09-01 |
| Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia (NCT00539123) | Yale University | 2007-09-01 |
| Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone (NCT00577408) | New York State Psychiatric Institute | 2007-09-01 |
| Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED) (NCT00684073) | Indivior Inc. | 2007-07-01 |
| Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED) (NCT00723697) | Indivior Inc. | 2007-05-01 |
| Effective Treatment of Hepatitis C in Substance Users (NCT00633243) | Yale University | 2007-04-01 |
| SSRI and Buprenorphine (NCT00475878) | Butler Hospital | 2006-12-01 |
| Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence (NCT00548275) | Yale University | 2006-07-01 |
| Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8 (NCT00218036) | The University of Texas Health Science Center, Houston | 2006-07-01 |
| Acceptance Therapy During Methadone Detoxification (NCT00439036) | The University of Texas Health Science Center, Houston | 2006-07-01 |
| Employment-Based Depot Naltrexone Clinical Trial (NCT00684788) | Johns Hopkins University | 2006-05-01 |
| Prescription Opioid Addiction Treatment Study (POATS) (NCT00316277) | Mclean Hospital | 2006-05-01 |
| HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group. (NCT00147784) | Sorlandet Hospital HF | 2006-03-01 |
| Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction (NCT00521157) | University of Oslo | 2006-01-01 |
| A Video-Based HCV Curriculum for Drug Users (NCT00241917) | Organization to Achieve Solutions in Substance Abuse (OASIS) | 2005-11-01 |
| Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants (NCT00130819) | Johns Hopkins University | 2005-11-01 |
| A Video-Based HCV Curriculum for Active Injection Drug Users (NCT00241943) | Organization to Achieve Solutions in Substance Abuse (OASIS) | 2005-11-01 |
| Substance Abuse Pre-Treatment Screening Study (NCT00439049) | The University of Texas Health Science Center, Houston | 2005-10-01 |
| Integrating Buprenorphine Into HIV Treatment (NCT00241930) | Organization to Achieve Solutions in Substance Abuse (OASIS) | 2005-09-01 |
| The Effects of Methadone and Buprenorphine on Fetal Neurobehavior and Infant Neonatal Abstinence Syndrome - 1 (NCT00218621) | Johns Hopkins University | 2005-09-01 |
| Counseling for Primary Care Office-based Buprenorphine (NCT00595764) | Yale University | 2005-08-01 |
| Bone Density and Serum Testosterone in Male Methadone Maintained Patients (NCT00170339) | Hennepin Healthcare Research Institute | 2005-04-01 |
| Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1 (NCT00129298) | National Institute on Drug Abuse (NIDA) | 2004-12-01 |
| Brief Introductory Therapy for Opioid Dependence (NCT00406484) | Yale University | 2004-09-01 |
| ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997]) (NCT00156936) | Alkermes, Inc. | 2004-08-01 |
| Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance (NCT00622596) | Yale University | 2003-10-01 |
| Clinical Efficacy of Disulfiram in LAAM-Maintained Cocaine Abusers (NCT00580827) | Yale University | 2003-09-01 |
| HIV Risk Reduction and Drug Abuse Treatment in Malaysia (NCT00383045) | Yale University | 2003-04-01 |
| Effects of Ketamine On Precipitated Opioid Withdrawal Under General Anaesthesia (NCT00300794) | Vilnius University | 2003-02-01 |
| Treatment of Polydrug-Using Opiate Dependents During Withdrawal (NCT00367874) | Sorlandet Hospital HF | 2003-02-01 |
| Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence (NCT00332228) | New York State Psychiatric Institute | 2002-06-01 |
| ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids (NCT01218984) | Alkermes, Inc. | 2002-03-01 |
| Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice (NCT00007527) | US Department of Veterans Affairs | 1999-08-01 |